Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
trypanosomiasis/carbohydrate
Länken sparas på Urklipp
Sida 1 från 22 resultat
Carbohydrate metabolism in bovine trypanosomiasis.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Carbohydrate metabolism in human trypanosomiasis.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Trypanosomiasis: an approach to chemotherapy by the inhibition of carbohydrate catabolism.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
When the infected mammalian host of Trypanosoma brucei brucei is injected with a solution of the iron chelator salicyl hydroxamic acid and glycerol, the aerobic and anaerobic glucose catabolism of the parasite is blocked and the parasite is rapidly destroyed.
Carbohydrate immunity in American trypanosomiasis.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Carbohydrate-Binding Non-Peptidic Pradimicins for the Treatment of Acute Sleeping Sickness in Murine Models.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Current treatments available for African sleeping sickness or human African trypanosomiasis (HAT) are limited, with poor efficacy and unacceptable safety profiles. Here, we report a new approach to address treatment of this disease based on the use of compounds that bind to parasite surface glycans
Carbohydrate-naphthalene diimide conjugates as potential antiparasitic drugs: Synthesis, evaluation and structure-activity studies.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The neglected tropical diseases Human African Trypanosomiasis and leishmaniasis are caused by infection with trypanosomatid parasites Trypanosoma brucei and Leishmania spp, respectively. The genomes of these organisms contain multiple putative G-quadruplex (G4) forming sequences which have recently
A plethora of targets, a paucity of drugs: progress towards the development of novel chemotherapies for human African trypanosomiasis.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Human African trypanosomiasis is a major health problem in large regions of Africa. Current chemotherapeutic options are limited and far from ideal. A diverse range of drug targets has been identified and validated in trypanosomes. These include several organelles (glycosomes, acidocalcisomes,
Gambiense human african trypanosomiasis and immunological memory: effect on phenotypic lymphocyte profiles and humoral immunity.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
In mice, experimental infection with Trypanosoma brucei causes decreased bone marrow B-cell development, abolished splenic B-cell maturation and loss of antibody mediated protection including vaccine induced memory responses. Nothing is known about this phenomenon in human African trypanosomiasis
Hemolymphatic components in vectors of Trypanosoma cruzi: study in several species of the subfamily Triatominae (Hemiptera: Reduviidae).
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The members of the subfamily Triatominae (Hemiptera: Reduviidae) comprise a great number of species of medical importance in the transmission of the T. cruzi (American trypanosomiasis). The aim of this study was to contribute to the knowledge about the chemical composition in proteins, lipids,
Antigenic glycans in parasitic infections: implications for vaccines and diagnostics.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Infections by parasitic protozoans and helminths are a major world-wide health concern, but no vaccines exist to the major human parasitic diseases, such as malaria, African trypanosomiasis, amebiasis, leishmaniasis, schistosomiasis, and lymphatic filariasis. Recent studies on a number of parasites
Targeting the Pentose Phosphate Pathway: Characterization of a New 6PGL Inhibitor.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Human African trypanosomiasis, or sleeping sickness, is a lethal disease caused by the protozoan parasite Trypanosoma brucei. However, although many efforts have been made to understand the biochemistry of this parasite, drug development has led to treatments that are of limited efficiency and of
Trypanosome variable surface antigens: studies using two-dimensional gel electrophoresis and monoclonal antibodies.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Variable surface antigens of cloned populations of African trypanosomes were studied using 2-dimensional gel electrophoresis and monoclonal antibodies. Two-dimensional gel maps showed that the only major differences in protein profiles of the non-nuclear materials from different clones of
[Diabetes mellitus induced by pentamidine, without previous episodes of hypoglycemia, in patients with AIDS].
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The onset of a pneumonia by P. carinii in AIDS patients have force scientist to look for others therapies against this parasite. It is more necessary when the first line treatment which is cotrimoxazol produced secondary effects or not therapeutic effects. Pentamidine which is an agent usually used
Trypanosoma cruzi cleaves galectin-3 N-terminal domain to suppress its innate microbicidal activity.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Galectin-3 is the best characterized member of galectins, an evolutionary conserved family of galactosides-binding proteins that play central roles in infection and immunity, regulating inflammation, cell migration, and cell apoptosis. Differentially expressed by cells and tissues with immune
Novel inhibitors of the trypanosome alternative oxidase inhibit Trypanosoma brucei brucei growth and respiration.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
African trypanosomiasis is a deadly disease for which few chemotherapeutic options are available. The causative agents, Trypanosoma brucei rhodesiense and T. b. gambiense, utilize a non-cytochrome, alternative oxidase (AOX) for their cellular respiration. The absence of this enzyme in mammalian
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
